company background image
MGTX logo

MeiraGTx Holdings NasdaqGS:MGTX Stock Report

Last Price

US$6.20

Market Cap

US$398.1m

7D

-4.9%

1Y

13.1%

Updated

18 Mar, 2024

Data

Company Financials +

MeiraGTx Holdings plc

NasdaqGS:MGTX Stock Report

Market Cap: US$398.1m

MGTX Stock Overview

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases.

MGTX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

MeiraGTx Holdings plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MeiraGTx Holdings
Historical stock prices
Current Share PriceUS$6.20
52 Week HighUS$8.35
52 Week LowUS$3.49
Beta1.3
1 Month Change2.31%
3 Month Change26.79%
1 Year Change13.14%
3 Year Change-61.08%
5 Year Change-65.36%
Change since IPO-58.67%

Recent News & Updates

MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met

Feb 15

Recent updates

MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met

Feb 15

Does MeiraGTx Holdings (NASDAQ:MGTX) Have A Healthy Balance Sheet?

Sep 08
Does MeiraGTx Holdings (NASDAQ:MGTX) Have A Healthy Balance Sheet?

Calculating The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX)

Apr 11
Calculating The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX)

MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Reducing Their Forecasts For This Year

Mar 16
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Reducing Their Forecasts For This Year

MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are More Bearish Than They Used To Be

Nov 16
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are More Bearish Than They Used To Be

MeiraGTx GAAP EPS of -$0.76, revenue of $10.76M

Aug 11

MeiraGTx inks $100M debt agreement backed by manufacturing facilities

Aug 03

MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans

Apr 29
MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans

Analysts' Revenue Estimates For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher

Mar 15
Analysts' Revenue Estimates For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher

MeiraGTx: Perceptive's Large Stake Makes It Interesting

Jan 19

MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans

Dec 28
MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans

MeiraGTx: Novel Riboswitch Technology Could Add Value

Nov 01

Shareholders Will Probably Hold Off On Increasing MeiraGTx Holdings plc's (NASDAQ:MGTX) CEO Compensation For The Time Being

Jun 05
Shareholders Will Probably Hold Off On Increasing MeiraGTx Holdings plc's (NASDAQ:MGTX) CEO Compensation For The Time Being

MeiraGTx Holdings'(NASDAQ:MGTX) Share Price Is Down 11% Over The Past Year.

Feb 22
MeiraGTx Holdings'(NASDAQ:MGTX) Share Price Is Down 11% Over The Past Year.

Is MeiraGTx Holdings plc (NASDAQ:MGTX) Popular Amongst Insiders?

Jan 18
Is MeiraGTx Holdings plc (NASDAQ:MGTX) Popular Amongst Insiders?

Are Insiders Selling MeiraGTx Holdings plc (NASDAQ:MGTX) Stock?

Dec 14
Are Insiders Selling MeiraGTx Holdings plc (NASDAQ:MGTX) Stock?

MeiraGTx slides on public offering pricing at $12.85/share

Nov 19

Shareholder Returns

MGTXUS BiotechsUS Market
7D-4.9%-2.1%-0.1%
1Y13.1%10.4%28.4%

Return vs Industry: MGTX exceeded the US Biotechs industry which returned 10.4% over the past year.

Return vs Market: MGTX underperformed the US Market which returned 28.4% over the past year.

Price Volatility

Is MGTX's price volatile compared to industry and market?
MGTX volatility
MGTX Average Weekly Movement13.2%
Biotechs Industry Average Movement11.9%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: MGTX's share price has been volatile over the past 3 months.

Volatility Over Time: MGTX's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2015422Alexandria Forbeshttps://meiragtx.com

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson’s program that has completed a Phase II trial.

MeiraGTx Holdings plc Fundamentals Summary

How do MeiraGTx Holdings's earnings and revenue compare to its market cap?
MGTX fundamental statistics
Market capUS$398.15m
Earnings (TTM)-US$84.03m
Revenue (TTM)US$14.02m

28.4x

P/S Ratio

-4.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MGTX income statement (TTM)
RevenueUS$14.02m
Cost of RevenueUS$0
Gross ProfitUS$14.02m
Other ExpensesUS$98.04m
Earnings-US$84.03m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.31
Gross Margin100.00%
Net Profit Margin-599.46%
Debt/Equity Ratio52.2%

How did MGTX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.